Search
for
Sort by
Research 391–420 of 1000+
- Difficult and rare forms of acne
- The frequency of polycystic ovary syndrome in females with resistant acne vulgaris
- Effects of isotretinoin on body mass index, serum adiponectin, leptin, and ghrelin levels in acne vulgaris patients
- Oral Contraceptives as Anti-Androgenic Treatment of Acne
- Nutritional and Microbial Strategies for Treating Acne, Alopecia, and Atopic Dermatitis
- Medicinal Plants and their Constituents in the Treatment of Acne vulgaris
- Menopausal Acne – Challenges And Solutions
- Acne related to dietary supplements
- The aetiopathogenesis of acne vulgaris - what's new?
- Exploring the Multifaceted Impact of Acne on Quality of Life and Well-Being
- Factors affecting the course and severity of adult acne. Observational cohort study
- The treatment of acne
- Dispelling myths about acne
- Acne vulgaris
- Azelaic Acid in the Treatment of Acne in Adult Females: Case Reports
- Acne: Diet and acnegenesis
- Acne and hirsuties in teenagers
- Effects of hyperandrogenism and high body mass index on acne severity in women.
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Desideratum dermatologicum--cause and control of premenstrual acne flare
- Trichostasis Spinulosa: A Clinical Simulant of Acne Open Comedones
- The relationship among androgens, insulin resistanceand ghrelin polymorphisms in post-adolescent malepatients with severe acne vulgaris
- Polycystic ovary syndrome and acne.
- Serum 3α-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris
- Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris
- Clinical and histopathological characteristics in patients with scarring folliculitis type of acne inversa
- Optimal laboratory testing protocol for patients with acne taking oral isotretinoin
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
- Uso de la espironolactona en dermatología: acné, hidradenitis supurativa, alopecia femenina e hirsutismo